Nasal Obstruction and Olfactory Losses
Ohio State University · NCT05920330
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 330
- US sites recruiting
- 1
- Study start
- January 25, 2023
- Record last updated
- May 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
About 13% of US adults, some 30 million people, suffer from nasal sinus disease. Although nasal obstruction and smell loss are two of the major symptoms of the disease that are crucial to disease management, currently there is a lack of clinical tools to effectively evaluate the mechanisms contributing to these symptoms. The proposed study aims to develop novel clinical tools to better evaluate and relieve patients' nasal obstructive symptoms and to enable patients and clinicians to make more informed, personalized decisions regarding treatment strategy.
Being studied: Nasal Plug
Conditions: Nasal Obstruction
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Smell Loss complaints
- Nasal Obstruction
Exclusion Criteria
- Congenital olfactory losses
- Nasal polyps, blocking the olfactory cleft
- Significant atrophy
- Cystic fibrosis
- Wegeners or any other connective tissue disorder
- Head trauma
Recruiting US locations
Eye and Ear Institute, 915 Olentangy River Road, ENT, Suite 4000
Columbus, OH 43212
Site contact: Veronica Formanek, BS · 630-501-8168 · Veronica.Formanek@osumc.edu
Study contacts (from the official record)
- Veronica Formanek, BS · 630-501-8168 · Veronica.Formanek@osumc.edu
- Beth Miles-Markley, MS · 614-366-9244 · Beth.Miles-Markley@osumc.edu
Similar studies in Ohio
All healthy volunteers studies in Ohio →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
LH-001 vs Placebo in Healthy Participants
Chien-Liang Lin
- Location
- Columbus, OH
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Beachwood, OH + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 50–75